ArticleClinical breast cancer2020

Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.

Kathleen Fenn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.